The Patent Finder

Karo Pharma AB

Also on record
Records under this name other than the patents Karo Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Karo Pharma AB

PatentTitleStatus Expires Confidence
US 9,974,776Estrogen receptor beta agonists for use in treating mesothelioma
Formerly held
Lapsed on the fee record
Ended May 22, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2026From the USPTO record
US 8,367,665Estrogen receptor ligands
Formerly held
Lapsed on the fee record
Ended Feb 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2025From the USPTO record
US 8,653,072Estrogen receptor ligands
Formerly held
Lapsed on the fee record
Ended Feb 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2022From the USPTO record
US 9,586,891Estrogen receptor ligands
Lapsed on the fee record
Ended Mar 7, 2021 · From the USPTO record
Lapsed on the fee recordEnded Mar 7, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited